Main Session
Sep
27
QP 15 - Boston Heme Party: Bite-Sized Breakthroughs
1086 - PD-1/PD-L1 Blockade Added to First-Line Asparaginase-Based Chemotherapy with or without Radiotherapy in Extranodal Nasal-Type NK/T-Cell Lymphoma: A Multicenter Retrospective Study from the CLCG
Presenter(s)
Yue Liu, MD - National Cancer Center CAMS & PUMC, Beijing, Beijing